MARS therapy, the bridging to liver retransplantation - Three cases from the Hungarian liver transplant program

about

MARS therapy, the bridging to liver retransplantation - Three cases from the Hungarian liver transplant program

Item

http://www.wikidata.org/entity/Q37319101

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MARS therapy, the bridging to ...... arian liver transplant program

@en

MARS therapy, the bridging to ...... rian liver transplant program.

@nl

type

Item

label

MARS therapy, the bridging to ...... arian liver transplant program

@en

MARS therapy, the bridging to ...... rian liver transplant program.

@nl

prefLabel

MARS therapy, the bridging to ...... arian liver transplant program

@en

MARS therapy, the bridging to ...... rian liver transplant program.

@nl

P1476

MARS therapy, the bridging to ...... arian liver transplant program

@en

P2093

Anikó Smudla

http://www.w3.org/2001/XMLSchema#string

Attila Doros

http://www.w3.org/2001/XMLSchema#string

Balázs Nemes

http://www.w3.org/2001/XMLSchema#string

Balázs Pőcze

http://www.w3.org/2001/XMLSchema#string

Dénes Görög

http://www.w3.org/2001/XMLSchema#string

Eszter Dabasi

http://www.w3.org/2001/XMLSchema#string

Eva Toronyi

http://www.w3.org/2001/XMLSchema#string

Gellért Tőzsér

http://www.w3.org/2001/XMLSchema#string

Gergely Zádori

http://www.w3.org/2001/XMLSchema#string

Gyula Végső

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.

Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.

Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure.

Molecular adsorbent recirculating system (MARS).

Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.

Review article: clinical experience with Prometheus.

Survival predictors in patients treated with a molecular adsorbent recirculating system

Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland.

Artificial extracorporeal liver support therapy in patients with severe liver failure.

Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy.

P304

70-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1556/IMAS.5.2013.2.3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Janos Fazakas

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24265893

http://www.w3.org/2001/XMLSchema#string

P932

3831804

http://www.w3.org/2001/XMLSchema#string